JPS5338631A - Treating composition for nerve and sympathetic nerve disease group - Google Patents

Treating composition for nerve and sympathetic nerve disease group

Info

Publication number
JPS5338631A
JPS5338631A JP8552977A JP8552977A JPS5338631A JP S5338631 A JPS5338631 A JP S5338631A JP 8552977 A JP8552977 A JP 8552977A JP 8552977 A JP8552977 A JP 8552977A JP S5338631 A JPS5338631 A JP S5338631A
Authority
JP
Japan
Prior art keywords
nerve
treating composition
disease group
sympathetic
sympathetic nerve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8552977A
Other languages
English (en)
Other versions
JPS554724B2 (ja
Inventor
Reon Tomine Mishieru
Pero Jiyatsuku
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of JPS5338631A publication Critical patent/JPS5338631A/ja
Publication of JPS554724B2 publication Critical patent/JPS554724B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP8552977A 1976-07-19 1977-07-15 Treating composition for nerve and sympathetic nerve disease group Granted JPS5338631A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622180A FR2358892A1 (fr) 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Publications (2)

Publication Number Publication Date
JPS5338631A true JPS5338631A (en) 1978-04-08
JPS554724B2 JPS554724B2 (ja) 1980-01-31

Family

ID=9175947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8552977A Granted JPS5338631A (en) 1976-07-19 1977-07-15 Treating composition for nerve and sympathetic nerve disease group

Country Status (38)

Country Link
US (1) US4499019A (ja)
JP (1) JPS5338631A (ja)
AR (1) AR214330A1 (ja)
AT (1) AT365570B (ja)
AU (1) AU509291B2 (ja)
BE (1) BE856289A (ja)
CH (1) CH627162A5 (ja)
CS (1) CS219885B2 (ja)
CY (1) CY1036A (ja)
DD (2) DD137670A5 (ja)
DK (1) DK156646C (ja)
EG (1) EG12911A (ja)
ES (1) ES460621A1 (ja)
FI (1) FI67213C (ja)
FR (1) FR2358892A1 (ja)
GB (1) GB1539319A (ja)
GR (1) GR60836B (ja)
HK (1) HK17880A (ja)
HU (1) HU174981B (ja)
IE (1) IE46171B1 (ja)
IL (1) IL52547A (ja)
IN (1) IN146993B (ja)
LU (1) LU77782A1 (ja)
MC (1) MC1153A1 (ja)
MX (1) MX4711E (ja)
NL (1) NL174347C (ja)
NO (1) NO146598C (ja)
NZ (1) NZ184634A (ja)
OA (1) OA05704A (ja)
PH (1) PH12838A (ja)
PL (1) PL104244B1 (ja)
PT (1) PT66819B (ja)
RO (1) RO71691A (ja)
SE (1) SE425243B (ja)
SU (1) SU695556A3 (ja)
YU (1) YU40677B (ja)
ZA (1) ZA774256B (ja)
ZM (1) ZM5477A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5639431A (en) * 1979-09-06 1981-04-15 Susumu Yagyu Colorimeter having two-light pass length and two-wave length

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
FR2478093A1 (fr) * 1980-03-12 1981-09-18 Ile De France Nouveau procede de preparation de n-(1-alkyl (ou allyl) 2-pyrrolidinyl-methyl)2-methoxy (ou 2,3-dimethoxy) 5-sulfamoyl (ou sulfamoyl substitue)
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
CN105481733A (zh) * 2015-12-30 2016-04-13 苏州诚和医药化学有限公司 一种一步法合成2-甲氧基-5-氨磺酰基苯甲酸甲酯的方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5639431A (en) * 1979-09-06 1981-04-15 Susumu Yagyu Colorimeter having two-light pass length and two-wave length

Also Published As

Publication number Publication date
AU509291B2 (en) 1980-05-01
CH627162A5 (ja) 1981-12-31
CY1036A (en) 1980-08-01
DD132492A5 (de) 1978-10-04
PH12838A (en) 1979-09-05
FI67213C (fi) 1985-02-11
FI67213B (fi) 1984-10-31
DD137670A5 (de) 1979-09-19
RO71691A (ro) 1982-09-09
NO146598C (no) 1982-11-03
IE46171B1 (en) 1983-03-23
AU2702677A (en) 1979-01-18
SE7708176L (sv) 1978-01-20
ES460621A1 (es) 1978-05-01
DK156646C (da) 1990-02-05
FR2358892A1 (fr) 1978-02-17
NL174347C (nl) 1984-06-01
FI772214A (ja) 1978-01-20
SE425243B (sv) 1982-09-13
PL199723A1 (pl) 1978-04-24
PL104244B1 (pl) 1979-08-31
ATA511677A (de) 1981-06-15
PT66819B (fr) 1978-12-22
ZM5477A1 (en) 1978-05-22
ZA774256B (en) 1978-06-28
AR214330A1 (es) 1979-05-31
IL52547A0 (en) 1977-10-31
US4499019A (en) 1985-02-12
AT365570B (de) 1982-01-25
OA05704A (fr) 1981-05-31
NL174347B (nl) 1984-01-02
IL52547A (en) 1980-01-31
NO772530L (no) 1978-01-20
YU40677B (en) 1986-04-30
JPS554724B2 (ja) 1980-01-31
NO146598B (no) 1982-07-26
MC1153A1 (fr) 1978-04-17
NZ184634A (en) 1978-11-13
SU695556A3 (ru) 1979-10-30
IE46171L (en) 1978-01-19
HK17880A (en) 1980-04-11
CS219885B2 (en) 1983-03-25
IN146993B (ja) 1979-10-20
NL7707982A (nl) 1978-01-23
DK326377A (da) 1978-01-20
BE856289A (fr) 1977-12-30
GB1539319A (en) 1979-01-31
EG12911A (en) 1980-12-31
MX4711E (es) 1982-08-11
DK156646B (da) 1989-09-18
GR60836B (en) 1978-08-31
HU174981B (hu) 1980-04-28
LU77782A1 (ja) 1977-10-17
PT66819A (fr) 1977-08-01
YU173977A (en) 1983-01-21
FR2358892B1 (ja) 1978-12-15

Similar Documents

Publication Publication Date Title
JPS5317572A (en) Improvement for treating substances
JPS52128229A (en) Arthritis treating medical composition
JPS53139734A (en) Keratin treating composition
JPS5634621A (en) Dimethylsulfoxideecontaining treating composition
ZA77424B (en) Skin treatment composition
ZA761570B (en) Treating solid fuel
AU2438977A (en) Mesotherapeutic treatment
JPS539324A (en) Treating composition
JPS5225036A (en) Cattle disease treating composition and treating method
JPS52125634A (en) Composition for burn treatment
JPS5446842A (en) Skin treating composition
JPS5417114A (en) Dislanol composition for treating favus disease
IL51429A (en) Coccidiocidal composition for treating
JPS53130433A (en) Composition and method for treating hyperchromocyte skin disease
ZA77907B (en) Hair treating composition
JPS5338631A (en) Treating composition for nerve and sympathetic nerve disease group
JPS5394030A (en) Bruise treating composition
JPS52126913A (en) Composition effective for treating soil
PH16705A (en) Method for treating hyperacidity and disorders related thereto
SG41482G (en) Medicaments for treating hypertension
JPS52120131A (en) Treating composition for rercholesterol disease
JPS545047A (en) Composition for treating bacterial disease
JPS55120514A (en) Composition for local treatment
JPS5244242A (en) Treating composition for chronic skin disease and eye disease
JPS53121939A (en) Novel treating composition